TY - JOUR
T1 - Adapting to the global shortage of cholera vaccines
T2 - targeted single dose cholera vaccine in response to an outbreak in South Sudan
AU - Parker, Lucy A.
AU - Rumunu, John
AU - Jamet, Christine
AU - Kenyi, Yona
AU - Lino, Richard Laku
AU - Wamala, Joseph F.
AU - Mpairwe, Allan M.
AU - Ciglenecki, Iza
AU - Luquero, Francisco J.
AU - Azman, Andrew S.
AU - Cabrol, Jean Clement
N1 - Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Shortages of vaccines for epidemic diseases, such as cholera, meningitis, and yellow fever, have become common over the past decade, hampering efforts to control outbreaks through mass reactive vaccination campaigns. Additionally, various epidemiological, political, and logistical challenges, which are poorly documented in the literature, often lead to delays in reactive campaigns, ultimately reducing the effect of vaccination. In June 2015, a cholera outbreak occurred in Juba, South Sudan, and because of the global shortage of oral cholera vaccine, authorities were unable to secure sufficient doses to vaccinate the entire at-risk population—approximately 1 million people. In this Personal View, we document the first public health use of a reduced, single-dose regimen of oral cholera vaccine, and show the details of the decision-making process and timeline. We also make recommendations to help improve reactive vaccination campaigns against cholera, and discuss the importance of new and flexible context-specific dose regimens and vaccination strategies.
AB - Shortages of vaccines for epidemic diseases, such as cholera, meningitis, and yellow fever, have become common over the past decade, hampering efforts to control outbreaks through mass reactive vaccination campaigns. Additionally, various epidemiological, political, and logistical challenges, which are poorly documented in the literature, often lead to delays in reactive campaigns, ultimately reducing the effect of vaccination. In June 2015, a cholera outbreak occurred in Juba, South Sudan, and because of the global shortage of oral cholera vaccine, authorities were unable to secure sufficient doses to vaccinate the entire at-risk population—approximately 1 million people. In this Personal View, we document the first public health use of a reduced, single-dose regimen of oral cholera vaccine, and show the details of the decision-making process and timeline. We also make recommendations to help improve reactive vaccination campaigns against cholera, and discuss the importance of new and flexible context-specific dose regimens and vaccination strategies.
UR - http://www.scopus.com/inward/record.url?scp=85009747746&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009747746&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(16)30472-8
DO - 10.1016/S1473-3099(16)30472-8
M3 - Review article
C2 - 28109819
AN - SCOPUS:85009747746
SN - 1473-3099
VL - 17
SP - e123-e127
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 4
ER -